Analytical Data
-
Gene name
ACBD4
- Application
-
Alternative Names
ACBD 4; ACBD4; ACBD4_HUMAN; Acyl CoA binding domain containing protein 4; Acyl coenzyme A binding domain containing 4; Acyl-CoA-binding domain-containing protein 4
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NC06
-
Expression Region
1-305aa
-
Molecular Weight
50.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACBD4, or Acyl-CoA Binding Domain Containing 4, is a protein that plays a crucial role in lipid metabolism and cellular signaling. Research into ACBD4 has gained momentum due to its involvement in various physiological processes, including cellular stress response, regulation of lipid droplet dynamics, and mitochondrial function. Recent studies have suggested that ACBD4 may be implicated in metabolic disorders, such as obesity and diabetes, as well as in the pathophysiology of certain cancers. Understanding the structure and function of ACBD4 is essential for elucidating its role in these conditions. Researchers are particularly interested in its acyl-CoA binding capability, which may influence fatty acid transport and metabolism within cells. The investigation of ACBD4 may also provide insights into therapeutic targets for metabolic diseases, making it a significant focus in the fields of biochemistry and molecular biology. Advances in recombinant DNA technology have enabled the production of ACBD4 fusion proteins, facilitating the study of its interactions and functional mechanisms. Overall, the research surrounding ACBD4 not only enhances our understanding of lipid metabolism but also opens new avenues for potential clinical applications in metabolic health and disease management.
